These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 18906656)

  • 1. The use of BAL (2,3 dimercaptopropanol) in arsenical encephalopathy.
    DANBY CW
    Can Med Assoc J; 1948 Mar; 58(3):284. PubMed ID: 18906656
    [No Abstract]   [Full Text] [Related]  

  • 2. Arsenical encephalopathy treated with B. A. L.
    KONAR NR; DASS AK
    Calcutta Med J; 1950 Jun; 47(6):188-90. PubMed ID: 14772650
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical uses of 2,3-dimercaptopropanol (BAL); the treatment of arsenical dermatitis with preparations of BAL.
    LONGCOPE WT; LUETSCHER JA
    J Clin Invest; 1946 Jul; 25(4):528-33. PubMed ID: 21001626
    [No Abstract]   [Full Text] [Related]  

  • 4. The treatment of arsenical dermatitis with dimercaptopropanol (BAL).
    CARLETON AB; PETERS RA; THOMPSON RH
    Q J Med; 1948 Jan; 17(65):49-79. PubMed ID: 18905506
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical uses of 2,3-dimercaptopropanol (BAL); the effect of BAL on the excretion of arsenic in arsenical intoxication.
    LUETSCHER JA; EAGLE H; LONG-COPE WT
    J Clin Invest; 1946 Jul; 25(4):534-40. PubMed ID: 21001627
    [No Abstract]   [Full Text] [Related]  

  • 6. Suppression of treponemicidal action of arsenic with 2,3-dimercaptopropanol (BAL) report of clinical observations in five cases.
    De OREO GA
    Arch Derm Syphilol; 1947 Nov; 56(5):695-8. PubMed ID: 20272216
    [No Abstract]   [Full Text] [Related]  

  • 7. [Arsenical encephalopathy; clinical case cured with BAL, similar case without treatment with fatal outcome].
    MONTERO R; BEATO J
    Rev Chil Pediatr; 1952 May; 23(5):179-84. PubMed ID: 14949536
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical uses of 2,3-dimercaptopropanol (BAL); the treatment of lewisite burns of the eye with BAL.
    HUGHES WF
    J Clin Invest; 1946 Jul; 25(4):541-8. PubMed ID: 21001628
    [No Abstract]   [Full Text] [Related]  

  • 9. The treatment of lewisite and other arsenical vesicant lesions of the eyes of rabbits with British anti-lewisite (BAL).
    MANN I; PIRIE A; PULLINGER BD
    Am J Ophthalmol; 1947 Apr; 30(4):421-35. PubMed ID: 20256316
    [No Abstract]   [Full Text] [Related]  

  • 10. The fate of arsenical vesicants in the skin and the effect of BAL (British anti-lewisite).
    Graham AF; Levvy GA; Chance AC
    Biochem J; 1947; 41(3):352-7. PubMed ID: 16748172
    [No Abstract]   [Full Text] [Related]  

  • 11. Substituent effects on the binding constants of arsenical-dithiol adducts.
    Dill K; Huang LH; McGown EL; Youn SH; O'Connor RJ
    Res Commun Chem Pathol Pharmacol; 1991 Jun; 72(3):367-70. PubMed ID: 1947439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative binding constants of arsenical-antidote adducts determined by NMR spectroscopy.
    O'Connor RJ; McGown EL; Dill K; Hallowell SF
    Res Commun Chem Pathol Pharmacol; 1990 Sep; 69(3):365-8. PubMed ID: 2173085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. British anti-lewisite; a report on its use and therapeutic value in arsenical intoxications, from the BAL Conference, Medical Research Council.
    PETERS RA; BENNET J
    Br Med J; 1947 Oct; 2(4526):520. PubMed ID: 20267003
    [No Abstract]   [Full Text] [Related]  

  • 14. [B.A.L treatment of arsenical poisoning].
    MIGNOLET F; HEUSGHEM C; BACQ ZM
    Acta Clin Belg; 1947; 2():199-204. PubMed ID: 20269203
    [No Abstract]   [Full Text] [Related]  

  • 15. [BAL in the treatment of intoxication by arsenical and gold preparations].
    BERMUDEZ ABREU VP
    Rev Kuba Med Trop Parasitol; 1950; 6(3-4):59-65. PubMed ID: 15441436
    [No Abstract]   [Full Text] [Related]  

  • 16. [BAL; a new potent antidote in arsenical and heavy metal poisoning].
    FERRANTI-LAURENZI A
    Gazz Med Ital; 1951 Dec; 110(12):399-401. PubMed ID: 14906734
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of 2,3-dimercaptopropanol (BAL) on the whole blood and plasma concentration of arsenic after mapharsen in cats.
    RIKER WF; ROSENFELD G
    J Pharmacol Exp Ther; 1946 Aug; 87(4 Suppl):72-5. PubMed ID: 20275115
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathologic study of ocular lesions due to lewisite (B-chlorovinyldichloroarsine) changes with and without BAL (2,3-dimercaptopropanol) therapy.
    ADLER FH; FRY WE; LEOPOLD IH
    Arch Ophthal; 1947 Jul; 38(1):89-108. PubMed ID: 20258239
    [No Abstract]   [Full Text] [Related]  

  • 19. The treatment by 2,3-dimercaptopropanol (BAL) of the systemic toxic effects of skin contamination with lewisite and phenyldichlorarsine.
    HARRISON HE; DURLACHER SH
    J Pharmacol Exp Ther; 1946 Aug; 87(4 Suppl):81-4. PubMed ID: 20275117
    [No Abstract]   [Full Text] [Related]  

  • 20. Poisoning from inhalation of the vapors of lewisite and phenyldichlorarsine; its pathology in the dog and treatment with 2,3-dimercaptopropanol (BAL).
    HARRISON HE; ORDWAY NK
    J Pharmacol Exp Ther; 1946 Aug; 87(4 Suppl):76-80. PubMed ID: 20275116
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.